SCHEMBL6656271

SCHEMBL6656271

NC(=O)[C@@H]1CCCN1Oc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SPHK1 Q9NYA1 2/20 0.48
SPHK2 Q9NRA0 1/20 0.46
ELANE P08246 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
DPP4 P27487 3/20 0.41
AR P10275 1/20 0.41
SCN3A Q9NY46 1/20 0.41
POLB P06746 1/20 0.41
SCN9A Q15858 1/20 0.40
DPP8 Q6V1X1 1/20 0.39
DPP7 Q9UHL4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6654304 0.92 SPHK1 (0.43) ALDH1A1SMN1; SMN2SPHK1SPHK2ELANE
SCHEMBL7016050 0.87 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2KDM4EMAPK1HTT
SCHEMBL7016053 0.87 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2KDM4EMAPK1HTT
SCHEMBL6417166 0.84 L3MBTL1 (0.46) SPHK1SPHK2ELANEHTTSCN3A
SCHEMBL8911799 0.82 LTA4H (0.49) ALDH1A1SMN1; SMN2KDM4EMAPK1HTT
SCHEMBL7026294 0.82 LTA4H (0.49) ALDH1A1SMN1; SMN2KDM4EMAPK1HTT
Hydrochloric Acid SCHEMBL5941225 0.81 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KDM4EMAPK1HTT
Trifluoroacetic Acid SCHEMBL6658125 0.80 AKR1C3 (0.40) SPHK1SPHK2SCN3ASCN9A
SCHEMBL18474160 0.79 DPP4 (0.45) ALDH1A1SMN1; SMN2SPHK1SPHK2ELANE
SCHEMBL18474217 0.79 DPP4 (0.45) ALDH1A1SMN1; SMN2SPHK1SPHK2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434580-A2 ALLYLAMIDES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-07-07 EP disclosed
WO-2003030886-A2 ALLYLAMIDES USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC (US) 2003-04-17 WO disclosed